A testosterone patch can provide a modest but meaningful improvement in postmenopausal libido for women not taking estrogen.
A testosterone patch can provide a modest but meaningful improvement in postmenopausal libido for women not taking estrogen, according to research published in the Nov. 6 issue of the New England Journal of Medicine.
Susan R. Davis, MD, PhD, of Monash University in Prahran, Australia, and colleagues conducted a double-blind, placebo-controlled trial of 814 women with low libido who were randomized to receive a patch delivering 150 or 300 µg a day of testosterone or placebo for a period of 52 weeks.
At week 24, the researchers measured the efficacy of the hormone and found that for the 300 µg testosterone group, there was an increase in the 4-week frequency of satisfying sexual episodes of 2.1 versus 1.2 for the 150-µg group and 0.7 for the placebo group. Women in both treatment groups reported increased desire and decreased distress, the study showed. However, women in the 300-µg treatment group had more androgenic adverse events, such as unwanted hair growth, the investigators found.
The research was supported by grants from Procter & Gamble Pharmaceuticals. Several of the study authors report financial relationships with the pharmaceutical industry.
Davis SR, Moreau M, Kroll R, et al.Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med. 2008;359:2005-2017.
Regulatory T cell alterations in early pregnancy linked to spontaneous preterm labor
February 18th 2025A recent study reveals that specific Treg subpopulation changes in the first trimester may contribute to spontaneous preterm labor, shedding light on the role of immune regulation in pregnancy outcomes.
Read More
Late third-trimester ultrasound accurately predicts large for gestational age births
February 17th 2025A new study confirms that estimating fetal weight with ultrasound between 35 to 38 weeks’ gestation strongly predicts large for gestational age births, helping guide clinical management decisions.
Read More